Cure Pharmtech successfully ended 2022 Arab Health

8 Feb 2022
Views 185

(Source: Arab Health official website)

Cure Pharmtech participated in 2022 Arab Health with its subsidiary Cure Biotech Co., Ltd. and ended in success.

More than 3,500 companies related to medicines, medical devices, and medical services from more than 60 countries participated in the 2022 Arab Health held at Dubai World Trade Centre in the United Arab Emirates.

Cure Pharmtech Co., Ltd. introduced a new product, functional suture ‘DDSLINE’, along with biopolymer material ‘CURE Glycolide’, pellet-type ‘CURESORB’, and absorbable suture ‘CURELINE’ which brought many visitors’ attention and inquiries on the product.

Currently, the offline exhibition has ended, but the online exhibition is available until February 28, 2022.

Link to Cure Pharmtech Co., Ltd. Online Exhibition:

Link to Cure Biotech Co., Ltd. Online Exhibition:

Thank you for your lots of support and interest.